BG
CNXC icon

Bahl & Gaynor’s Concentrix CNXC Stock Holding History

Bahl & Gaynor’s Portfolio CNXC Stock Details CNXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,672
Closed -$203K – 347
2023
Q1 		$203K Hold
1,672
– – ﹤0.01% 332
2022
Q4 		$223K Buy
+1,672
New +$203K ﹤0.01% 324
2022
Q3 		– Sell
-1,774
Closed -$241K – 321
2022
Q2 		$241K Sell
1,774
-442
-20% -$66.5K ﹤0.01% 306
2022
Q1 		$369K Sell
2,216
-1,184
-35% -$225K ﹤0.01% 300
2021
Q4 		$607K Hold
3,400
– – ﹤0.01% 279
2021
Q3 		$602K Sell
3,400
-200
-6% -$33.1K ﹤0.01% 280
2021
Q2 		$579K Sell
3,600
-460
-11% -$70.8K ﹤0.01% 284
2021
Q1 		$608K Hold
4,060
– – ﹤0.01% 279
2020
Q4 		$401K Buy
+4,060
New +$406K ﹤0.01% 292

Other funds holding CNXC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LAM
Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Bahl & Gaynor's CNXC Position: Q2 2023 in Review

Bahl & Gaynor sold out of Concentrix (CNXC) in Q2 2023, closing a stake of 1,672 shares — an estimated $203K sold.

Bahl & Gaynor first reported a position in CNXC in Q4 2020 and held it in 9 quarters. The position peaked at $608K in Q1 2021. 316 funds tracked by Wall St. Rank hold CNXC as of Q2 2023.

  • Bahl & Gaynor reported no remaining Concentrix position as of Q2 2023 after selling out during the quarter.
  • Bahl & Gaynor sold 1,672 Concentrix shares in Q2 2023, an estimated $203K.
  • Bahl & Gaynor first reported a position in Concentrix in Q4 2020 and held it in 9 quarters.
  • Bahl & Gaynor's Concentrix position peaked at $608K in Q1 2021.
  • 316 funds tracked by Wall St. Rank held Concentrix as of Q2 2023.

Based on Bahl & Gaynor's 13F filing for Q2 2023, filed 14 Aug 2023.